Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

CCR5-blockade in Metastatic Colorectal Cancer (MARACON)

This study has been completed.
Sponsor:
Collaborator:
University Hospital Heidelberg
Information provided by (Responsible Party):
National Center for Tumor Diseases, Heidelberg
ClinicalTrials.gov Identifier:
NCT01736813
First received: October 24, 2012
Last updated: October 1, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2014
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)